Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
August-2014 Volume 8 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2014 Volume 8 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner

  • Authors:
    • Marina Hara
    • Masahiro Kuroda
    • Yuichi Ohmura
    • Hidenobu Matsuzaki
    • Tomoki Kobayashi
    • Jun Murakami
    • Kazunori Katashima
    • Masakazu Ashida
    • Seiichiro Ohno
    • Jun‑Ichi Asaumi
  • View Affiliations / Copyright

    Affiliations: Department of Oral and Maxillofacial Radiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700‑8558, Japan, Department of Radiological Technology, Graduate School of Health Sciences, Okayama University, Okayama 700‑8558, Japan, Department of Oral Diagnosis and Dentomaxillofacial Radiology, Okayama University Hospital, Okayama University, Okayama 700‑8558, Japan, Central Division of Radiology, Okayama University Hospital, Okayama University, Okayama 700‑8558, Japan
  • Pages: 819-824
    |
    Published online on: May 28, 2014
       https://doi.org/10.3892/ol.2014.2187
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of this study was to create a new phantom for a 3 Tesla (3T) magnetic resonance imaging (MRI) device for the calculation of the apparent diffusion coefficient (ADC) using diffusion‑weighted imaging (DWI), and to mimic the ADC values of normal and tumor tissues at various temperatures, including the physiological body temperature of 37˚C. The phantom was produced using several concentrations of sucrose from 0 to 1.2 M, and the DWI was performed using various phantom temperatures. The accurate ADC values were calculated using the DWIs of the phantoms, and an empirical formula was developed to calculate the ADC values of the phantoms from an arbitrary sucrose concentration and arbitrary phantom temperature. The empirical formula was able to produce ADC values ranging between 0.33 and 3.02x10‑3 mm2/sec, which covered the range of ADC values of the human body that have been measured clinically by 3T MRI in previous studies. The phantom and empirical formula developed in this study may be available to mimic the ADC values of the clinical human lesion by 3T MRI.

Introduction

Diffusion-weighted magnetic resonance imaging (MRI) has been increasingly performed for clinical purposes, including the detection of tumors and cerebrovascular diseases. The apparent diffusion coefficient (ADC) value, which is calculated based on diffusion-weighted imaging (DWI) using several b values, is useful for discriminating whether the lesion is benign or malignant and determining the therapeutic effect of a tumor. Recently, popularized 3 Tesla (3T) MRI devices have shown a performance advantage when calculating accurate ADC values. Several clinical studies have revealed that ADC values from 3T MRI have the diagnostic value as a quantitative parameter (1–8). However, to the best of our knowledge, there are no reports of an ADC phantom for 3T MRI. With regard to ADC phantoms for 1.5T MRI, Tamura et al (9) reported a phantom that used gelatin and sucrose. While Matsuya et al (10) reported a phantom using polyethylene glycol for 1.5T MRI, and created empirical formulas to calculate polyethylene glycol concentration, which provide arbitrary ADC values at any temperature measurement. In principle, the ADC value of a phantom differs due to its temperature. In the present study, an ADC phantom was developed using sucrose for 3T MRI, which produces arbitrary ADC values due to a range of phantom temperatures (28–39°C), which includes the physiological body temperature. This is the first temperature-controlled ADC phantom for 3T MRI, which mimics the ADC values of the normal and tumor tissues of the human body. In addition, the developed empirical formula enables the calculation of a sucrose concentration that provides arbitrary ADC values at any phantom temperature.

Materials and methods

Sucrose phantoms

To create the sucrose phantoms, sucrose (S0389-500G; Sigma-Aldrich, St. Louis, MO, USA), NaN3 (28-1789-5; Sigma-Aldrich, Tokyo, Japan), as an antiseptic, and distilled water were heated and stirred until dissolved. The solution was cooled and the final concentrations of sucrose and NaN3 were adjusted to 0.2, 0.4, 0.6, 0.8, 1.0 and 1.2 M, and 0.03% (w/w), respectively. These solutions were then filled into phantom cases (No1-4628-11; As One Co., Osaka, Japan; Fig. 1A) as sucrose phantoms.

Figure 1

Phantom and methods used for the experiments. (A) Sucrose phantom in its case and (B) case container. Up to 16 sucrose phantoms could be placed into this container filled with 0.9 M sucrose solutions containing 0.03% (w/w) NaN3. (C) The heating box made of Styrofoam, which encloses the phantom case container. The container could be heated in the gantry of a magnetic resonance imaging scanner via a tube that was connected to a (D) circulating temperature-regulated water bath. (E) The optical fiber thermometer for temperature monitoring, which was placed into the phantoms. (F) The region of interest was 7.27 mm2 at the position of the thermometer on each diffusion-weighted image.

Preparation for the MRI of sucrose phantoms

Sucrose phantoms were placed into a container filled with 0.9 M sucrose solution and 0.03% (w/w) NaN3. The container was able to hold a maximum of 16 phantoms (Fig. 1B).

Heating system

The phantom case container was enclosed in a heating box (Fig. 1C) made of Styrofoam that was produced in-house (Department of Radiological Technology, Graduate School of Health Sciences, Okayama University, Okayama, Japan). The container was heated in the gantry of an MRI scanner via a tube that was connected to a circulating temperature-regulated water bath (Thermo-Mate BF-41; Yamato Scientific Co., Ltd., Tokyo, Japan; Fig. 1D), to maintain the desired phantom temperature during the MRI.

Real-time phantom temperature monitoring

Optical fiber thermometers (Fluoroptic™ thermometer m600; Luxtron Co., Mountain View, CA, USA; Fig. 1E) were placed into the phantoms. The phantom temperature was monitored every 30 sec during the MRI to ensure a constant temperature.

MRI

A clinical 3T MRI unit (Magnetom Skyra; Siemens, Erlangen, Germany) with a head coil was used for the MRI. DW images were acquired by a three-scan trace, in the phase-encoding, readout and slice-selective directions, via a single-shot echo-planar imaging sequence. The scan parameters were set as follows: 8,000 msec of relation time; 100 msec of echo time; 220×220-mm field of view; 160×112 matrix; b values of 0, 300, 600, 900, 1200, 1500, 1800, 2100, 2400, 2700 and 3000 sec/mm2; a thickness of 5 mm; one excitation number; 26.2-msec diffusion gradient pulse duration (δ); and 47.1-msec diffusion time (Δ), which was the interval between the onset of the diffusion gradient pulses. Each DW image of a maximum of four phantoms was obtained at each ~1°C interval to cover the physiological body temperature within the range of 28–39°C.

Accurate measurement of ADC values

The region of interest (ROI; Fig. 1F) was 7.27 mm2 at the position of the thermometer on each phantom DW image. The average signal intensity in each ROI was obtained using Image-J software (National Institutes of Health, Bethesda, MD, USA). The logarithms of these signal intensities were plotted as a function of the 11 b values of 0, 300, 600, 900, 1200, 1500, 1800, 2100, 2400, 2700 and 3000 sec/mm2. The slope of the regression line, which is defined as the ADC value, and its R2 value were obtained by the least-squares method. The 10 sets of ADC values and their R2 values were obtained for each set of data, from 11 DW images using 11 b values to two DW images using two b values, in order of decreasing b value. We used 10 sets of DW images using the following combination of b values; 0, 300, 600, 900, 1200, 1500, 1800, 2100, 2400, 2700 and 3000; 0, 300, 600, 900, 1200, 1500, 1800, 2100, 2400 and 2700; 0, 300, 600, 900, 1200, 1500, 1800, 2100 and 2400; 0, 300, 600, 900, 1200, 1500, 1800 and 2100; 0, 300, 600, 900, 1200, 1500 and 1800 / 0, 300, 600, 900, 1200 and 1500; 0, 300, 600, 900 and 1200; 0, 300, 600 and 900; 0, 300 and 600; 0 and 300. When the R2 values exceeded 0.99 according to a decrease in b value, the ADC values from its set of b values was determined to be accurate; specifically, the b value used was within the range that the signal intensities remained above the noise, and where the slope of the logarithms of the signal intensities versus b values became linear. These accurate ADC values were used to create the following empirical formula.

Empirical formula for calculating phantom ADC values

ADC values of the phantoms were plotted as a function of the temperature from 28–39°C at 1°C intervals for each sucrose concentration of 0, 0.2, 0.4, 0.6, 0.8, 1.0 and 1.2 M. The linear equations were determined for each sucrose concentration based on a first-order approximation of the correlation between the ADC values and the phantom temperature. The first-order coefficients and intercepts of the seven linear equations were also plotted as a function of the sucrose concentrations. Subsequently, two formulas were created; one based on the fourth-order approximation of the correlation between the first-order coefficients and sucrose concentrations, with the other based on the fourth-order approximation of the correlation between the intercepts and sucrose concentrations. Using these two formulas, an empirical formula was developed for calculating ADC values of phantoms that were made of arbitrary sucrose concentrations at arbitrary phantom temperatures.

Validation of the accuracy of the empirical formula

To validate the accuracy of the empirical formula, new phantoms were produced using sucrose concentrations of 0.2, 0.4, 0.6, 0.8, 1.0 and 1.2 M. Three phantoms were made of each concentration and all sucrose concentrations were used three times independently. The mean ADC values were obtained at each concentration. The ADC values of these verification phantoms were measured at phantom temperatures ranging from 28–39°C at 1°C intervals. The experimental mean ADC values of these verification phantoms were compared with the ADC values calculated using the empirical formula by substituting the sucrose concentrations and phantom temperatures at measurement. The correlation between the ADC values calculated using the empirical formula and the range of the standard deviations (SDs) of the experimental ADC values of the verification phantoms were then validated.

Results

Calculation accuracy of ADC values

For each concentration and temperature of the sucrose phantoms, the ADC values were calculated. The 10 sets of ADC values and their R2 values were obtained by the least-squares method for each set of data from 11 DW images using 11 b values to two DW images using two b values in order of decreasing b value. As an example, Fig. 2 indicates the procedure to calculate the ADC value of a 0.2 M phantom at a temperature of 37.09°C. Among 10 sets of ADC values and their R2 values, when the maximum b value decreased to 1,500 sec/mm2 (Fig. 2E), the R2 value obtained for the set of data from six DW images using six b values exceeded 0.99 to become 0.9935. According to the slope calculation using this set, the ADC value of the 0.2 M phantom became 3.72×10−3, which was confirmed to be accurate. Finally, the ADC values were selected for all concentrations and temperatures, as shown in Fig. 3A.

Figure 2

Calculation of apparent diffusion coefficient values of a 0.2 M phantom at 37.09°C. The vertical axis indicates the logarithm of the signal intensity of the regions of interest in the diffusion-weighted image of the phantom. The horizontal axis indicates b values. ‘♦’ represents the data that were used for the least-squares method to obtain the regression line and the R2 value. ‘⋄’ represents the data that were not used for the least-squares method to obtain the regression line and the R2 value.

Figure 3

The ADC values of the phantoms and the development of an empirical formula to calculate the ADC values. (A) The change of ADC values by temperature. The vertical axis indicates the ADC values and the horizontal axis indicates the phantom temperature. Sucrose phantom concentrations of ⋄, 0; ■, 0.2; ▲, 0.4; ×, 0.6; *, 0.8; ●, 1.0; and +, 1.2 M. Each straight line indicates a first-order approximation of the correlation between the ADC values and the phantom temperature for each sucrose concentration. The (B) first-order coefficients and (C) intercepts of these linear equations are plotted. Each R2 value for the first-order approximation was within the range of 0.9379–0.9801. (B) The correlations between the sucrose concentrations and the first-order coefficients of linear equations from the first-order approximation. Black diamonds indicate first-order coefficients, while the curved line indicates the fourth-order approximation, with R2=0.9638. (C) The correlations between sucrose concentrations and the intercepts of the linear equations from the first-order approximation. Black diamonds indicate intercepts, while the curved line indicates the fourth-order approximation, with R2=0.9862. ADC, apparent diffusion coefficient.

Change in the ADC value of sucrose phantoms by temperature

The ADC values of the 0, 0.2, 0.4, 0.6, 0.8, 1.0 and 1.2 M phantoms are plotted in Fig. 3A as a function of temperature. The ADC values of the phantoms of each sucrose concentration increased with increasing phantom temperature. The increasing rate of the ADC value per 1°C increased as the sucrose concentration decreased.

Development of an empirical formula to calculate ADC values

Seven linear equations were developed based on a first-order approximation of the correlation between the ADC values and phantom temperature (t) for each sucrose concentration (s), as shown in Fig. 3A. The values of these R2 were within the range of 0.9379–0.9801. The first-order coefficients (A) and intercepts (B) of the seven linear equations were plotted as a function of sucrose concentrations (s), as shown in Fig. 3B and C, respectively. Each formula was developed based on a fourth-order approximation of the correlation between the first-order coefficients or intercepts and sucrose concentrations. The R2 values were 0.9638 and 0.9862, respectively. Using these relational formulas, an empirical formula was developed for calculating the ADC values of phantoms consisting of an arbitrary sucrose concentration (s) at arbitrary phantom temperature (t), as follows: ADC value (x10−3 mm2/sec) = At + B, where A = a1s4 − a2s3 + a3s2 − a4s + a5 (a1=8.96519842127907×10−7, a2=2.94479295800953×10−5, a3=6.94789261608819×10−5, a4=6.5038339758676×10−5 and a5=6.22597789270809×10−5) and B = −b1s4 + b2s3 −b3s2 + b4s + b5 (b1=5.75284527700504×10−4, b2=2.48741270074326×10−3, b3=3.12590711150129×10−3, b4=1.19937338765919×10−4 and b5=5.94518521028771×10−4).

Validation of the accuracy of the empirical formula

Fig. 4A indicates the calculated ADC values using the empirical formula shown as the three-dimensional graph with the correlation among ADC values, sucrose concentration and phantom temperature. The ADC values decreased according to an increase in sucrose concentration and decrease in phantom temperature. Fig. 4B indicates the correlation between the ADC values, which have been used to make the empirical formula, and the ADC values calculated using the empirical formula. The formula appears to mimic well all the ADC values that were initially used to create it. Fig. 4C indicates the correlation between the ADC values measured using the verification phantoms and the ADC values calculated using the empirical formula. In total, 66.67% of the calculated ADC values were less than one SD away from the mean of the measured ADC values of verification phantoms; 97.22% of the calculated ADC values were less than two SDs away from the mean; and 100% of calculated ADC values were less than three SDs away from the mean.

Figure 4

Calculated ADC values and validation of the accuracy using the empirical formula. The vertical axis indicates the ADC values and the horizontal axes indicate sucrose concentration and phantom temperature, respectively. Black cubes in each figure indicate the ADC values that were calculated from the empirical formula. (A) The ADC values which were calculated from the empirical formula. (B) The correlation between the predetermined and calculated ADC values using the empirical formula. The crosses (×) indicate the ADC values used to make the empirical formula. (C) The correlation between the ADC values measured using verification phantoms and the ADC values calculated using the empirical formula. The crosses (×) and vertical lines indicate the mean ± three standard deviations of the ADC values measured using verification phantoms. ADC, apparent diffusion coefficient.

Discussion

To the best of our knowledge, this is the first study to report ADC phantoms for DW images with 3T MRI. ADC phantoms were produced for 3T MRI using sucrose, and an empirical formula was developed to calculate ADC values between 0.33–3.02×10−3 at arbitrary sucrose concentrations between 0–1.2 M and arbitrary phantom temperatures between 28–39°C, including the physiological temperature of 37°C to mimic the normal and tumor tissue of the human body.

Sucrose, a large molecule with the formula of C12H22O11, is a safe and inexpensive material, with a concentration that can be easily controlled. The diffusion coefficient of the material (D) was associated with the temperature (t), the viscosity of the medium (η), and the radius of the diffusion molecule (r) using the Stokes-Einstein equation (11): D = kt/6πηr, where k is the Boltzmann constant (1.3805×10−23 J K−1). Therefore, sucrose with a large molecular size of 0.9 nm in diameter was selected as the material for the phantoms to decrease the ADC values (12).

According to the Stokes-Einstein equation, ADC values are affected by the temperature of the objects in question. As the ADC values used in clinical MRI diagnosis are measured for the human body at 37°C, ADC phantoms that mimic human body tissue should be comparable. Sasaki et al (13) measured the ADC values of bio-phantoms using human Burkitt’s lymphoma cells at 37°C; however, the majority of in vitro studies have performed the ADC measurement at a lower temperature (14–16). Tamura et al (9) reported an ADC phantom using 10–50% (wt/wt) sucrose for 1.5T MRI, which covers the range of ADC values between 0.2 and 1.8×10−3 mm2/sec for temperatures between 6 and 20°C. In the pre-examination of the present study, the ADC values were measured at temperatures between 6–39°C. The R2 values of the first-order approximation of the correlation between the ADC values and phantom temperature were low for phantoms of high sucrose concentration at temperatures of <27°C. Therefore, the temperature range of 28–39°C was used to create the empirical formula.

This empirical formula covered ADC values from 0.672.47×10−3 mm2/sec at a physiological temperature of 37°C. The ADC values of the phantoms almost covered the ADC values of the normal and tumor tissues of the human body that are measured clinically by 3T MRI, as summarized in Table I (1,3,5–8,17–19). Table I indicates the sucrose concentration of the ADC phantoms at 37°C, which mimic each tissue of the human body using the empirical formula.

Table I

Sucrose concentration mimicking ADC values of human body.

Table I

Sucrose concentration mimicking ADC values of human body.

Regions (ref)Mean ADC values, ×10−3 mm2/secSucrose concentration, M
Lesions
 Brain
  Lymphoma (6)0.62b~1.2
 Head and neck
  Squamous cell carcinoma (1)1.100.86
 Thyroid gland
  Malignant tumor (19)0.81c1.07
  Benign tumor (19)1.55c0.61
 Pancreas
  Neoplastic cystic lesion (7)2.60b0.13
  Mucinous cystic lesion (7)2.60b0.13
 Uterine cervix
  Malignant tumor (3)0.88b1.02
 Ovary
  Malignant tumor (8)1.04a0.91
  Benign tumor (8)1.15a0.84
 Prostate
  Peripheral zone tissue
   Malignant tumor (17)0.85d1.04
   Benign tumor (17) 1.17d0.82
  Transition zone tissue
   Malignant tumor (17) 0.84d1.05
   Benign tumor (17) 1.08d0.88
Normal tissues
 Brain
  White matter (18) 0.76b1.11
  Gray matter (18) 0.78b1.10
 Muscle
  Gluteus (3) 1.24a0.78
 Prostate
  Central gland (17) 1.19d0.81
  Peripheral gland (17) 1.54d0.61
 Tyroid tissue (19) 1.32c0.73

[i] b values at a0–800, b0–1,000, c0–1,500 and d0–2,000 sec/mm2. ADC, apparent diffusion coefficient.

One limitation of this study was that the sucrose phantoms produced ADC values due to changes in free diffusion alone. The actual in vivo diffusion in the human body is affected not only by the change of free diffusion, but also various factors, including perfusion and the change of restricted diffusion, due to cellular membrane structures and cell density (20–26). This new ADC phantom and empirical formula for 3T MRI has the potential to be used in a number of applications.

Acknowledgements

The authors would like to thank the staff members of the Department of Radiology and Central Division of Radiology of Okayama University Hospital (Okayama, Japan) for their support of this study. This study was partially supported by a Grant-in-Aid for Scientific Research [grant no. C (22591335)] from the Ministry of Health, Labour and Welfare of Japan (Tokyo, Japan).

References

1 

Srinivasan A, Dvorak R, Rohrer S and Mukherji SK: Initial experience of 3-tesla apparent diffusion coefficient values in characterizing squamous cell carcinomas of the head and neck. Acta Radiol. 49:1079–1084. 2008.

2 

Jung SH, Heo SH, Kim JW, et al: Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging. 35:110–116. 2012.

3 

Kim HS, Kim CK, Park BK, Huh SJ and Kim B: Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging. J Magn Reson Imaging. 37:187–193. 2013.

4 

Jensen LR, Garzon B, Heldahl MG, et al: Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients. J Magn Reson Imaging. 34:1099–1109. 2011.

5 

Abdel Razek AA, Elkhamary S, Al-Mesfer S and Alkatan HM: Correlation of apparent diffusion coefficient at 3T with prognostic parameters of retinoblastoma. AJNR Am J Neuroradiol. 33:944–948. 2012.

6 

Doskaliyev A, Yamasaki F, Ohtaki M, et al: Lymphomas and glioblastomas: Differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. Eur J Radiol. 81:339–344. 2012.

7 

Mottola JC, Sahni VA, Erturk SM, et al: Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results. Abdom Imaging. 37:110–117. 2012.

8 

Uehara T, Takahama J, Marugami N, et al: Visualization of ovarian tumors using 3T MR imaging: diagnostic effectiveness and difficulties. Magn Reson Med Sci. 11:171–178. 2012.

9 

Tamura T, Usui S and Akiyama M: Investigation of a phantom for diffusion weighted imaging that controlled the apparent diffusion coefficient using gelatin and sucrose. Nihon Hoshasen Gijutsu Gakkai Zasshi. 65:1485–1493. 2009.(In Japanese).

10 

Matsuya R, Kuroda M, Matsumoto Y, et al: A new phantom using polyethylene glycol as an apparent diffusion coefficient standard for MR imaging. Int J Oncol. 35:893–900. 2009.

11 

Einstein A: Investigations on the Theory of the Brownian Movement. Fürth R: Dover Publications, Inc; New York, NY: pp. p811956

12 

Ramm LE, Whitlow MB and Mayer MM: Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8 and C9 molecules required for a single channel. Proc Natl Acad Sci USA. 79:4751–4755. 1982.

13 

Sasaki T, Kuroda M, Katashima K, et al: In vitro assessment of factors affecting the apparent diffusion coefficient of Ramos cells using bio-phantoms. Acta Med Okayama. 66:263–270. 2012.

14 

Anderson AW, Xie J, Pizzonia J, et al: Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging. 18:689–695. 2000.

15 

Roth Y, Ocherashvilli A, Daniels D, et al: Quantification of water compartmentation in cell suspensions by diffusion-weighted and T(2)-weighted MRI. Magn Reson Imaging. 26:88–102. 2008.

16 

Pilatus U, Shim H, Artemov D, et al: Intracellular volume and apparent diffusion constants of perfused cancer cell cultures, as measured by NMR. Magn Reson Med. 37:825–832. 1997.

17 

Kitajima K, Takahashi S, Ueno Y, et al: Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm2) and standard high b-value (1000 s/mm2). J Magn Reson Imaging. 36:198–205. 2012.

18 

Cihangiroglu M, Ulug AM, Firat Z, et al: High b-value diffusion-weighted MR imaging of normal brain at 3T. Eur J Radiol. 69:454–458. 2009.

19 

Ilica AT, Artas H, Ayan A, et al: Initial experience of 3 tesla apparent diffusion coefficient values in differentiating benign and malignant thyroid nodules. J Magn Reson Imaging. 37:1077–1082. 2013.

20 

Lyng H, Haraldseth O and Rofstad EK: Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med. 43:828–836. 2000.

21 

Kim H, Morgan DE, Buchsbaum DJ, et al: Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res. 68:8369–8376. 2008.

22 

Kamel IR, Bluemke DA, Ramsey D, et al: Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol. 181:708–710. 2003.

23 

Lang P, Wendland MF, Saeed M, et al: Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology. 206:227–235. 1998.

24 

Gibbs P, Liney GP, Pickles MD, et al: Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol. 44:572–576. 2009.

25 

Guo AC, Cummings TJ, Dash RC and Provenzale JM: Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology. 224:177–183. 2002.

26 

Thoeny HC, De Keyzer F, Chen F, et al: Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology. 234:756–764. 2005.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hara M, Kuroda M, Ohmura Y, Matsuzaki H, Kobayashi T, Murakami J, Katashima K, Ashida M, Ohno S, Asaumi JI, Asaumi JI, et al: A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner. Oncol Lett 8: 819-824, 2014.
APA
Hara, M., Kuroda, M., Ohmura, Y., Matsuzaki, H., Kobayashi, T., Murakami, J. ... Asaumi, J. (2014). A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner. Oncology Letters, 8, 819-824. https://doi.org/10.3892/ol.2014.2187
MLA
Hara, M., Kuroda, M., Ohmura, Y., Matsuzaki, H., Kobayashi, T., Murakami, J., Katashima, K., Ashida, M., Ohno, S., Asaumi, J."A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner". Oncology Letters 8.2 (2014): 819-824.
Chicago
Hara, M., Kuroda, M., Ohmura, Y., Matsuzaki, H., Kobayashi, T., Murakami, J., Katashima, K., Ashida, M., Ohno, S., Asaumi, J."A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner". Oncology Letters 8, no. 2 (2014): 819-824. https://doi.org/10.3892/ol.2014.2187
Copy and paste a formatted citation
x
Spandidos Publications style
Hara M, Kuroda M, Ohmura Y, Matsuzaki H, Kobayashi T, Murakami J, Katashima K, Ashida M, Ohno S, Asaumi JI, Asaumi JI, et al: A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner. Oncol Lett 8: 819-824, 2014.
APA
Hara, M., Kuroda, M., Ohmura, Y., Matsuzaki, H., Kobayashi, T., Murakami, J. ... Asaumi, J. (2014). A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner. Oncology Letters, 8, 819-824. https://doi.org/10.3892/ol.2014.2187
MLA
Hara, M., Kuroda, M., Ohmura, Y., Matsuzaki, H., Kobayashi, T., Murakami, J., Katashima, K., Ashida, M., Ohno, S., Asaumi, J."A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner". Oncology Letters 8.2 (2014): 819-824.
Chicago
Hara, M., Kuroda, M., Ohmura, Y., Matsuzaki, H., Kobayashi, T., Murakami, J., Katashima, K., Ashida, M., Ohno, S., Asaumi, J."A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner". Oncology Letters 8, no. 2 (2014): 819-824. https://doi.org/10.3892/ol.2014.2187
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team